AMY THAYER: Open Payments
NPI 1992161210 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 42 payments from 15 companies in 2025. Trend: 2023 $762 · 2024 $1,049 · 2025 $934
Food & beverage: $839Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $212 |
| UCB, Inc. | 3 | $119 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $107 |
| Janssen Biotech, Inc. | 5 | $90 |
| Novartis Pharmaceuticals Corporation | 2 | $68 |
| Almirall LLC | 4 | $65 |
| Lilly USA, LLC | 2 | $55 |
| Galderma Laboratories, L.P. | 2 | $40 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
Products named: SKYRIZI, Bimzelx, TREMFYA, TALTZ, Klisyri, AKLIEF, Zoryve, Rhapsido.
Industry payments across MO — which companies pay providers there.
